• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前哨淋巴结活检不会增加原发性皮肤黑色素瘤患者发生途中转移的发生率。

A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma.

作者信息

van Poll Daan, Thompson John F, Colman Marjorie H, McKinnon J Gregory, Saw Robyn P M, Stretch Jonathan R, Scolyer Richard A, Uren Roger F

机构信息

Sydney Melanoma Unit, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales 2050, Australia.

出版信息

Ann Surg Oncol. 2005 Aug;12(8):597-608. doi: 10.1245/ASO.2005.08.012. Epub 2005 Jun 16.

DOI:10.1245/ASO.2005.08.012
PMID:16021534
Abstract

BACKGROUND

It has been suggested that performing a sentinel node biopsy (SNB) in patients with cutaneous melanoma increases the incidence of in-transit metastasis (ITM).

METHODS

ITM rates for 2018 patients with primary melanomas > or =1.0 mm thick treated at a single institution between 1991 and 2000 according to 3 protocols were compared: wide local excision (WLE) only (n = 1035), WLE plus SNB (n = 754), and WLE plus elective lymph node dissection (n = 229).

RESULTS

The incidence of ITM for the three protocols was 4.9%, 3.6%, and 5.7%, respectively (not significant), and as a first site of recurrent disease the incidence was 2.5%, 2.4%, and 4.4%, respectively (not significant). The subset of patients who were node positive after SNB and after elective lymph node dissection also had similar ITM rates (10.8% and 7.1%, respectively; P = .11). On multivariate analysis, primary tumor thickness and patient age predicted ITM as a first recurrence, but type of treatment did not. Patients who underwent WLE only and who had a subsequent therapeutic lymph node dissection (n = 149) had an ITM rate of 24.2%, compared with 10.8% in patients with a tumor-positive sentinel node treated with immediate dissection (n = 102; P = .03).

CONCLUSIONS

Performing an SNB in patients with melanoma treated by WLE does not increase the incidence of ITM.

摘要

背景

有人提出,对皮肤黑色素瘤患者进行前哨淋巴结活检(SNB)会增加途中转移(ITM)的发生率。

方法

比较了1991年至2000年间在单一机构按照3种方案治疗的2018例原发性黑色素瘤厚度≥1.0 mm患者的ITM发生率:仅行广泛局部切除(WLE)(n = 1035)、WLE加SNB(n = 754)以及WLE加选择性淋巴结清扫(n = 229)。

结果

三种方案的ITM发生率分别为4.9%、3.6%和5.7%(无显著差异),作为复发性疾病的首发部位,发生率分别为2.5%、2.4%和4.4%(无显著差异)。SNB后和选择性淋巴结清扫后淋巴结阳性的患者亚组的ITM发生率也相似(分别为10.8%和7.1%;P = 0.11)。多因素分析显示,原发性肿瘤厚度和患者年龄可预测ITM作为首次复发,但治疗方式不能。仅接受WLE且随后进行治疗性淋巴结清扫的患者(n = 149)的ITM发生率为24.2%,而立即进行清扫的前哨淋巴结肿瘤阳性患者(n = 102)的ITM发生率为10.8%(P = 0.03)。

结论

对接受WLE治疗的黑色素瘤患者进行SNB不会增加ITM的发生率。

相似文献

1
A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma.前哨淋巴结活检不会增加原发性皮肤黑色素瘤患者发生途中转移的发生率。
Ann Surg Oncol. 2005 Aug;12(8):597-608. doi: 10.1245/ASO.2005.08.012. Epub 2005 Jun 16.
2
Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma.前哨淋巴结切除术不会增加原发性黑色素瘤发生途中转移的发生率。
J Clin Oncol. 2005 Jul 20;23(21):4764-70. doi: 10.1200/JCO.2005.20.537.
3
Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.原发性黑色素瘤患者先前进行广泛局部切除术后淋巴管造影和前哨淋巴结活检的准确性。
Cancer. 2006 Dec 1;107(11):2647-52. doi: 10.1002/cncr.22320.
4
Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.对于皮肤黑色素瘤患者,前哨淋巴结活检比选择性淋巴结清扫能提供更准确的分期。
Ann Surg Oncol. 2004 Sep;11(9):829-36. doi: 10.1245/ASO.2004.01.026. Epub 2004 Aug 16.
5
Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.皮肤黑色素瘤患者前哨淋巴结活检结果为假阴性的生存分析及临床病理因素
Ann Surg Oncol. 2006 Dec;13(12):1655-63. doi: 10.1245/s10434-006-9066-0. Epub 2006 Oct 3.
6
[Prognosis after sentinel node biopsy in malignant melanoma].[恶性黑色素瘤前哨淋巴结活检后的预后]
Ugeskr Laeger. 2006 Jun 19;168(25):2457-62.
7
In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection.黑色素瘤患者在前哨淋巴结活检和治疗性淋巴结清扫术后出现的转移/局部复发情况。
Eur J Cancer. 2006 Jan;42(2):159-64. doi: 10.1016/j.ejca.2005.10.012. Epub 2005 Dec 1.
8
Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.皮肤黑色素瘤前哨淋巴结活检:一项病例对照研究。
Ann Surg Oncol. 2007 Dec;14(12):3566-74. doi: 10.1245/s10434-007-9606-2. Epub 2007 Oct 9.
9
High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma.黑色素瘤患者前哨淋巴结活检后区域淋巴结转移发生率高。
Br J Surg. 2004 Oct;91(10):1370-1. doi: 10.1002/bjs.4692.
10
Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases : personal experience and literature meta-analysis.早期(前哨淋巴结活检指导)与延迟淋巴结切除术在有淋巴结转移的黑色素瘤患者中的应用:个人经验和文献荟萃分析。
Cancer. 2010 Mar 1;116(5):1201-9. doi: 10.1002/cncr.24852.

引用本文的文献

1
A bibliometric analysis of sentinel lymph node biopsy in melanoma of the top 90 cited publications.对黑色素瘤前90篇被引用文献中前哨淋巴结活检的文献计量学分析。
Melanoma Manag. 2025 Dec;12(1):2494979. doi: 10.1080/20450885.2025.2494979. Epub 2025 Apr 28.
2
Association of tumor molecular factors with in-transit metastasis in primary cutaneous melanoma.肿瘤分子因素与原发性皮肤黑色素瘤的转移相关性研究。
Int J Dermatol. 2022 Sep;61(9):1117-1123. doi: 10.1111/ijd.16141. Epub 2022 Mar 5.
3
The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options.
区域治疗在改善全身治疗选择时代中转移性黑色素瘤的作用。
Cancers (Basel). 2015 Jul 1;7(3):1154-77. doi: 10.3390/cancers7030830.
4
Regional therapies for in-transit disease.区域内转移病灶的治疗方法。
Surg Oncol Clin N Am. 2015 Apr;24(2):309-22. doi: 10.1016/j.soc.2014.12.008. Epub 2015 Jan 30.
5
Efficacy of repeat sentinel lymph node biopsy in patients who develop recurrent melanoma.重复前哨淋巴结活检在复发黑色素瘤患者中的疗效。
J Am Coll Surg. 2014 Apr;218(4):686-92. doi: 10.1016/j.jamcollsurg.2013.12.025. Epub 2013 Dec 24.
6
Surgical management of melanoma: an EORTC Melanoma Group survey.黑色素瘤的外科治疗:一项欧洲癌症研究与治疗组织黑色素瘤小组的调查。
Ecancermedicalscience. 2013 Mar 28;7:294. doi: 10.3332/ecancer.2013.294. Print 2013.
7
Plasma cytokine analysis in patients with advanced extremity melanoma undergoing isolated limb infusion.晚期肢体黑色素瘤患者行孤立肢体灌注治疗后的血浆细胞因子分析。
Ann Surg Oncol. 2013 Apr;20(4):1128-35. doi: 10.1245/s10434-012-2785-5. Epub 2013 Mar 2.
8
Sentinel lymph node biopsy for cutaneous melanoma: results of 10 years' experience in two regional training hospitals in the Netherlands.前哨淋巴结活检在皮肤黑色素瘤中的应用:荷兰两家区域培训医院 10 年经验。
Int J Clin Oncol. 2013 Jun;18(3):428-34. doi: 10.1007/s10147-012-0399-3. Epub 2012 Mar 9.
9
Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute.黑色素瘤前哨淋巴结活检:约翰·韦恩癌症研究所实施该手术的技术要点。
J Surg Oncol. 2010 Jun 15;101(8):669-76. doi: 10.1002/jso.21581.
10
Thick melanoma: prognostic value of positive sentinel nodes.厚型黑色素瘤:前哨淋巴结阳性的预后价值。
World J Surg. 2009 Nov;33(11):2464-8. doi: 10.1007/s00268-009-0159-3.